SPRO | Spero Therapeutics, Inc.Quick infos- Headquarters: Massachusetts, United States
Trade prices- Volume:
- Market Cap: 27.16M
- Prev closed:
- Open: 6.89
- High: 7.62
- Low: 6.83
- 52 week low: 6.51
- 52 week high: 19.87
- Dividends:No Dividends
Next ER: March 13, 2023 After Market Closes
Earnings History | Date | EPS / Forecast | Revenue / Forecast | | | May 11, 2023 | | | | | March 13, 2023 | - / -0.3533 | - / 866.67K | | | November 14, 2022 | -0.33 / -0.3 | 2M / 5.42M | | | August 10, 2022 | -0.87 / -0.9267 | 1.99M / 1.43M | Beat!
| | May 16, 2022 | -1.01 / -0.93 | 2.07M / 1.93M | Beat!
| | view more | Historical Data| Date | | Price | | Open | High | Low | | Vol | Change | ER |
|---|
| May 16, 2022 | | 1.71 | | 1.65 | 1.82 | 1.65 | | 452.76K | 0% | | | May 13, 2022 | | 1.71 | | 1.70 | 1.77 | 1.67 | | 506.49K | 0.59% | | | May 12, 2022 | | 1.70 | | 1.69 | 1.80 | 1.66 | | 507.82K | 0% | | | May 11, 2022 | | 1.70 | | 1.80 | 1.82 | 1.68 | | 394.24K | -3.41% | | | May 10, 2022 | | 1.76 | | 2.02 | 2.04 | 1.75 | | 491.81K | -6.88% | | | May 9, 2022 | | 1.89 | | 2.07 | 2.24 | 1.88 | | 724.09K | -8.7% | | | May 6, 2022 | | 2.07 | | 1.84 | 2.38 | 1.70 | | 2.37M | 12.50% | | | May 5, 2022 | | 1.84 | | 1.73 | 2.04 | 1.70 | | 1.74M | 5.14% | | | May 4, 2022 | | 1.75 | | 1.62 | 1.82 | 1.56 | | 3.17M | -5.41% | | | May 3, 2022 | | 1.85 | | 1.50 | 2.37 | 1.50 | | 17.61M | -63.65% | | | view more |
NASDAQ - Nasdaq Stock Market
More profiles and info about the companyNews - Spero Therapeutics Announces First Quarter 2022 Operating Results and Provides Business Update
 finance.yahoo.com Sep 26, 2022 4:05 pm - Spero (SPRO) Up Following Positive FDA Update for UTI Drug
finance.yahoo.com Sep 26, 2022 10:36 am - FDA Identifies Review Issues For Spero's Tebipenem Application, Shares Plunge
finance.yahoo.com Sep 26, 2022 9:59 am - Spero Therapeutics Stock More Than Doubles On GSK Pact For Its Lead Antibiotic
finance.yahoo.com Sep 26, 2022 7:20 am - Spero Therapeutics Announces New Strategic Direction Focusing on Advancing Promising Clinical-Stage Pipeline
finance.yahoo.com Sep 26, 2022 7:05 am - This Infection-Fighting Biotech Is Recovering Nicely
 realmoney.thestreet.com Sep 25, 2022 7:00 am - Spero stock soars 79% as GSK to pick stake under license deal for UTI antibiotic
 seekingalpha.com Sep 22, 2022 4:55 pm - GSK picks up troubled Spero drug for nearly $300M, takes stake in company
 bizjournals.com Sep 22, 2022 11:30 am - Spero Therapeutics appoints Kamal Hamed MD CMO
seekingalpha.com Sep 16, 2022 4:36 am - Spero Therapeutics Announces Appointment of Kamal Hamed, MD, MPH, MBA, as Chief Medical Officer
finance.yahoo.com Sep 15, 2022 4:05 pm - Spero jumps 64% as FDA clarifies future regulatory path for UTI candidate
seekingalpha.com Sep 7, 2022 4:01 am - Spero Therapeutics Shares Jump After Upbeat FDA Feedback For Tebipenem HBr Program
finance.yahoo.com Sep 6, 2022 10:10 am - Can Spero Therapeutics (NASDAQ:SPRO) Afford To Invest In Growth?
finance.yahoo.com Sep 5, 2022 6:49 am - Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com Aug 10, 2022 5:25 pm - Spero Therapeutics to Provide Business Update and Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022
finance.yahoo.com Aug 9, 2022 8:05 am - UPDATE 1-U.S. FDA declines to approve Spero's urinary tract infection drug
finance.yahoo.com Jun 27, 2022 4:27 pm - History of Short-Term Rentals Filled With Arrogance and Missed Opportunities
finance.yahoo.com May 31, 2022 7:30 am - Spero Therapeutics to Provide Business Update and Report First Quarter 2022 Financial Results on Monday, May 16, 2022
finance.yahoo.com May 9, 2022 8:05 am - Top 10 Losers on Tuesday
finance.yahoo.com May 3, 2022 5:29 pm - Spero Therapeutics to Present Data at the 32nd European Congress of Clinical Microbiology and Infectious Diseases
finance.yahoo.com Apr 21, 2022 8:05 am
This company doesn't provide a dividend. Talk about Spero Therapeutics, Inc. below in comments section below.Do you think you'll buy? Do you already have active trades now? | | Share it with fellow traders: or join discussions in FB below ( FB comments ) investors.sperotherapeutics.com If you are looking for News & events, Press Release, they are available on their Investors Relationssite. If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
More features coming soon :)  Buy on AmazonGraham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949. The best book on investing ever written.
-- Warren Buffet |
